How should Samarth Kulkarni, CEO of CRISPR Therapeutics, guide the company at a time when its path-breaking gene-editing treatment for two rare diseases struggles commercially?
CaseWorks
Search Cases
Featured Cases
This section highlights recently published cases.
How should The Nature Conservancy (TNC) prioritize and select future Nature Bonds projects, given limited conservation funding, variable environmental and financial returns, and high execution complexity?
Can Diego Cuenca and his team navigate legal and operational hurdles amid a global pandemic, to transform recently-acquired garage software developer Ticketech into a success story?
How should Marvel Fusion navigate the technological challenges of commercializing laser-based fusion energy while managing investor expectations and competing against both established nuclear fission technologies and magnet-based fusion alternatives?
What should business leaders consider when they think about AI deployment in investment and strategy development?